Hilltop Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.42M Sell
18,093
-1,103
-6% -$257K 1.13% 20
2025
Q4
$3.97M Buy
19,196
+618
+3% +$122K 1.02% 25
2025
Q3
$3.44M Buy
18,578
+1,159
+7% +$199K 1.03% 23
2025
Q2
$2.66M Buy
17,419
+3,453
+25% +$531K 0.8% 23
2025
Q1
$2.32M Sell
13,966
-939
-6% -$147K 0.78% 19
2024
Q4
$2.16M Buy
14,905
+3,385
+29% +$525K 0.73% 25
2024
Q3
$1.87M Buy
11,520
+670
+6% +$107K 0.63% 23
2024
Q2
$1.59M Buy
10,850
+2,138
+25% +$318K 0.59% 25
2024
Q1
$1.38M Buy
8,712
+5,195
+148% +$827K 0.49% 31
2023
Q4
$551K Buy
3,517
+1,575
+81% +$242K 0.22% 57
2023
Q3
$302K Buy
1,942
+327
+20% +$54K 0.13% 75
2023
Q2
$267K Buy
+1,615
New +$261K 0.11% 75
2023
Q1
Sell
-1,280
Closed -$226K 69
2022
Q4
$226K Buy
+1,280
New +$221K 0.12% 51

Other funds holding JNJ

Hilltop Partners's JNJ Position: Q1 2026 in Review

Hilltop Partners reduced its Johnson & Johnson (JNJ) stake by 5.7% in Q1 2026, selling an estimated $257K and leaving 18,093 shares worth $4.42M. The position accounts for 1.13% of the portfolio, ranked #20.

Hilltop Partners first reported a position in JNJ in Q4 2022 and has held it in 13 quarters since. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Hilltop Partners held 18,093 shares of Johnson & Johnson worth $4.42M as of Q1 2026.
  • Hilltop Partners sold 1,103 Johnson & Johnson shares in Q1 2026, an estimated $257K.
  • Johnson & Johnson made up 1.13% of Hilltop Partners's portfolio in Q1 2026, its #20 holding.
  • Hilltop Partners first reported a position in Johnson & Johnson in Q4 2022 and has held it in 13 quarters since.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Hilltop Partners's 13F filing for Q1 2026, filed 12 May 2026.